Consistent with the oncogenic mechanisms mentioned earlier in breast cancer, TET1 also inhibits tumor cell invasion by activating TIMPs, whose depletion promotes prostate cancer invasion and metastasis [262]. Here, TET1 is linked to prostate carcinoma.